| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |